Publisher: Edward Elgar Publishing Ltd
Number of pages: 424
Dimensions: 234 x 156 mm
'Dukes, Braithwaite and Moloney reach the depressing conclusion that "corporate crime in the pharmaceutical industry appears to be on the rise." Their approach to this problem is much more nuanced than just throwing people in jail. They advocate for a pyramid of regulatory strategies including qui tam legislation and equity fines. There is an opportunity for a radical transformation of the pharmaceutical industry and the authors offer us a road map to begin that journey.' -- Joel Lexchin MD, York University, Canada
'Given the provenance, this book was always going to be excellent, but it exceeded my highest expectations. It's one of those rare works that combine true scholarship with great imagination and ends up also a real pleasure to read. The breadth of analysis is remarkable and the modelling for better futures is superb. It's more than a must read book; it is a must heed commentary, a blueprint for better public health that would be perilous to ignore.' -- Charles Medawar, Founder of Social Audit and author of Power and Dependence: Social Audit on the Safety of Medicines
'This is a powerful book that demands to be read by all those concerned about the health of nations. It is also a call to arms for criminologists to turn a scholarly eye to the plethora of harms and crimes perpetrated by the pharmaceutical industry. Our response to this is long overdue.' -- Paddy Rawlinson, Australian & New Zealand Journal of Criminology
You may also be interested in...
Would you like to proceed to the App store to download the Waterstones App?
Or, add to basket, pay online, collect in as little as 2 hours, subject to availability.